NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.
NEJM Interviews - A podcast by NEJM Group - Wednesdays
Dr. Peter Marks is the director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.W. Marks, H.D. Marston, and L.R. Baden. End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations. N Engl J Med 2023;388:1153-1155.
